nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?
|
Wichaiyo, Surasak |
|
|
27 |
6 |
p. 1973-1990 |
artikel |
2 |
Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice
|
Alam, Amit |
|
|
27 |
6 |
p. 2083-2093 |
artikel |
3 |
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
|
Morfino, Paolo |
|
|
27 |
6 |
p. 2187-2200 |
artikel |
4 |
Association between electrical and mechanical remodeling after cardiac resynchronization therapy: systematic review and meta-analysis of observational studies
|
Pilecky, David |
|
|
27 |
6 |
p. 2165-2176 |
artikel |
5 |
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition
|
Manolis, Antonis S. |
|
|
27 |
6 |
p. 2119-2135 |
artikel |
6 |
Cardiorenal syndrome: long road between kidney and heart
|
Junho, Carolina Victoria Cruz |
|
|
27 |
6 |
p. 2137-2153 |
artikel |
7 |
Cardiovascular disease associated with methamphetamine use: a review
|
Tobolski, Jared |
|
|
27 |
6 |
p. 2059-2065 |
artikel |
8 |
Discussion of LBBP synchronization effects in HF patients with LBBB and comparison with BiV-CRT
|
Zhang, Shigeng |
|
|
27 |
6 |
p. 2181-2186 |
artikel |
9 |
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease
|
Horak, Martin |
|
|
27 |
6 |
p. 2251-2265 |
artikel |
10 |
Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here
|
Tribolet de Abreu, Tiago |
|
|
27 |
6 |
p. 2077-2082 |
artikel |
11 |
Is it time to revisit ICD indications?
|
Yehya, Amin |
|
|
27 |
6 |
p. 2177-2179 |
artikel |
12 |
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
|
Luo, Fanyan |
|
|
27 |
6 |
p. 2211-2221 |
artikel |
13 |
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021
|
Ilonze, Onyedika J. |
|
|
27 |
6 |
p. 2033-2043 |
artikel |
14 |
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging
|
Alexandridis, Georgios M. |
|
|
27 |
6 |
p. 2045-2058 |
artikel |
15 |
Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review
|
Lakhdar, Sofia |
|
|
27 |
6 |
p. 2201-2209 |
artikel |
16 |
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review
|
Bazoukis, George |
|
|
27 |
6 |
p. 2067-2076 |
artikel |
17 |
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making
|
Dandel, Michael |
|
|
27 |
6 |
p. 2017-2031 |
artikel |
18 |
Soluble ST2: a valuable prognostic marker in heart failure
|
Savarimuthu, Sugeevan |
|
|
27 |
6 |
p. 2155-2164 |
artikel |
19 |
The cardiosplenic axis: the prognostic role of the spleen in heart failure
|
Hiraiwa, Hiroaki |
|
|
27 |
6 |
p. 2005-2015 |
artikel |
20 |
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure
|
Anderson, Kelley M. |
|
|
27 |
6 |
p. 2223-2249 |
artikel |
21 |
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure
|
Triposkiadis, Filippos |
|
|
27 |
6 |
p. 1991-2003 |
artikel |
22 |
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature
|
Bazoukis, George |
|
|
27 |
6 |
p. 2095-2118 |
artikel |